Post job

G1 Therapeutics overview

Industry
Pharmaceuticals
Revenue
Headquarters
Employees
148
Founded in
Website
Organization type
Public
Social media
G1 Therapeutics is a clinical stage company developing novel cancer therapies. G1T was founded in 2008 by Drs. Norman Sharpless and Kwok-Kin Wong to capitalize on discoveries made and patented by Dr. Sharpless' lab at the University of North Carolina at Chapel Hill, and subsequently licensed to G1 Therapeutics. G1 Therapeutics is currently developing small molecules for Pharmacoquiescence™(PQ™).
G1 Therapeutics is a small pharmaceutical company based in North Carolina with only 148 employees and an annual revenue of $82.5M.

G1 Therapeutics's mission statement

Clear: to develop and deliver next generation therapies that improve the lives and outcomes of people living with cancer.

In demand companies are hiring! Let Zippia apply for you!

Floating question marks illustration
-

G1 Therapeutics employee reviews

Be the first to review!

Do you work at G1 Therapeutics?

Help job seekers learn about working at G1 Therapeutics

On this page

Be the first to review G1 Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at G1 Therapeutics?

The team at G1 Therapeutics

  • The founders of G1 Therapeutics are Norman E. Sharpless and Kwok Wong.
  • The key people at G1 Therapeutics are Jack Bailey, Norman E. Sharpless and Kwok Wong.
Key people
Jack Bailey
Norman E. Sharpless
Kwok Wong

G1 Therapeutics rankings

G1 Therapeutics is ranked #26 on the Best Pharmaceutical companies to work for in North Carolina list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate G1 Therapeutics' commitment to diversity and inclusion.

Zippia waving zebra

Do you work at G1 Therapeutics?

Did G1 Therapeutics' compensation package meet your expectations?

G1 Therapeutics financial performance

8.4
Performance score

We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.

G1 Therapeutics currently has 51.3M in revenue. G1 Therapeutics's most recent quarter produced 12.3m (q3'2023).

G1 Therapeutics annual revenue

$83M
$66M
$50M
$33M
$17M
$0
2020
2021
2022
2023

Are you an executive, HR leader, or brand manager at G1 Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

G1 Therapeutics FAQs

Search for jobs

Zippia gives an in-depth look into the details of G1 Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about G1 Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at G1 Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by G1 Therapeutics. The data presented on this page does not represent the view of G1 Therapeutics and its employees or that of Zippia.

G1 Therapeutics may also be known as or be related to G1 THERAPEUTICS INC., G1 Therapeutics, G1 Therapeutics Inc, G1 Therapeutics, Inc. and G1Therapeutics, Inc.